To determine whether AF1q-mediated alterations of CML cells are mainly caused by CD44, we used a specific CD44 monoclonal antibody, A3D8, to block CD44 activity in K562-AF1q cells. Here, MLLT11 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.